MarzocchettiA, SchwarzJ, DI GiambenedettoS, ColafigliM, BraccialeL, FabbianiM, FantoniM, TrecarichiEM, CaudaR, De LucaA. The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected caucasians starting antiretroviral therapy. AIDS Res Hum Retroviruses, 2011; 27,12:1299–1309.
2.
VelosoS, OlonaM, PeraireJ, ViladésC, PardoP, DomingoP, AsensiV, BrochM, AguilarC, López-DuplaM, AragonésG, Garcia-PardoG, SirventJJ, VendrellJ, RichartC, VidalF. the HIV Lipodystrophy Study Group: No relationship between TNF-α genetic variants and combination antiretroviral therapy-related lipodystrophy syndrome in HIV type 1-infected patients: a case-control study and a meta-analysis. AIDS Res Hum Retroviruses, 2011; 27,2:143–152.
3.
Zanone PomaB, RivaA, NasiM, CicconiP, BrogginiV, LepriAC, MologniD, MazzottaF, MonforteAD, MussiniC, CossarizzaA, GalliM. the Icona Foundation Study Group: Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. AIDS, 2008; 22,14:1769–1778.
